Globe Life Inc.'s Stock Increase: Major Investments & Future Outlook

Interval Partners LP has increased its stake in Globe Life Inc. by 28.5% in the third quarter, as detailed in its latest SEC filing. The firm now holds 137,105 shares, accumulating to a value of approximately $19.6 million. This move represents about 0.17% of Globe Life's total shares.

Other significant investors have also been active in Globe Life's stock market. Invesco Ltd. raised its holdings by 3.9% in the second quarter, resulting in 3,921,439 shares valued at about $487.4 million. Geode Capital Management LLC and Dimensional Fund Advisors LP each increased their Globe Life shareholdings by 2.9%. AQR Capital Management LLC notably almost doubled its position, acquiring an additional 696,548 shares. Notably, Norges Bank initiated a new stake in this period, valued around $157.7 million. Currently, institutional investors own 81.61% of Globe Life's shares.

On the stock market, Globe Life opened at $138.51 recently, with a market capitalization of $10.89 billion. Its price-to-earnings ratio is noted at 9.84, and it carries a beta of 0.46. The company has recorded a one-year price range between $109.38 and $152.71.

In its most recent earnings report, Globe Life disclosed a quarterly earnings per share (EPS) of $3.39, slightly below the expected $3.44. The company achieved a return on equity of 21.30% and reported revenue of $1.52 billion for the quarter, reflecting a 3.6% increase from the same quarter of the previous year. The firm anticipates EPS guidance between 14.95 and 15.65 for FY 2026, with analysts predicting an EPS of 13.87 for the current year.

Globe Life declared a quarterly dividend increase to $0.33 per share, to be distributed on May 1. This equates to an annual dividend of $1.32 and a 1.0% yield. The payout ratio stands at 7.67%.

In the opinion of various financial analysts, Globe Life remains a favorable investment. Several firms, including TD Cowen, Morgan Stanley, and Truist Financial, maintain positive ratings, with target price evaluations trending upward. MarketBeat.com gathers that Globe Life currently has a consensus "Moderate Buy" from eight research analysts.

The company underwent notable insider trading activities, with Director Mark A. Blinn and CEO James Matthew Darden reducing their holdings. Blinn's transaction on February 6 involved the sale of 1,750 shares priced at $147.91 each. Meanwhile, Darden offloaded 18,318 shares at an average of $145.10 per share in March.

As a leading underwriter and distributor, Globe Life, listed on the NYSE under GL, provides a comprehensive array of life and supplemental health insurance offerings. Its subsidiary brands offer affordable life insurance policies, annuities, and supplemental coverages catering to a diverse customer base across different socioeconomic groups.